this was the secondary target, they failed the first - from...

this was the secondary target, they failed the first - from todays Age
"In March, Sirtex disclosed that results from its so-called Sirflox trial had shown little improvement in overall survival for cancer patients treated with the company's radioactive spheres, which was the primary aim of the study. But on Thursday, further details from the same trial has demonstrated the efficacy of its treatment in cases of liver cancer, which was the secondary target of the trial."